BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
16.06
-0.83 (-4.91%)
At close: Sep 17, 2025, 4:00 PM EDT
16.38
+0.32 (1.99%)
After-hours: Sep 17, 2025, 4:33 PM EDT
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $310.56 million as of September 17, 2025. Its market cap has increased by 140.12% in one year.
Market Cap
310.56M
Enterprise Value
238.17M
1-Year Change
140.12%
Ranking
Category
Stock Price
$16.06
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $310.56M, an increase of 73.57%. That is a compound annual growth rate of 4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 310.56M | 72.18% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | 79.04M | -26.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |